Bridging Innovative RNA Biology and Drug Discovery
Our mission:
By combining multidisciplinary academic innovators with biotech-inspired objectives and focus, our goal is to uncover novel disease solutions by advancing the science of RNA regulation, developing new technological platforms, and discovering early-stage therapeutics.
Our Approach:
Recruit and nucleate current and next generation leaders in RNA biology and cultivate environment of collaboration, technology innovation and entrepreneurship
Build multi-disciplinary drug discovery teams focused on translating transformative RNA discoveries into therapeutics utilizing biotech best practices
Integrate academic innovators with therapeutic teams to bridge the gap between discovery and clinically applicable therapies
CENTER Happenings
recent media & publications
Congratulations to the Westbrook lab who was awarded a CPRIT grant to study the HUSH complex in breast cancer!
Drs. Nick Neill and Trey Westbrook recently published “Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer” in Cancer Discovery. Congratulations!
Congratulations to Khoa Dao, Dr. Tony Mustoe, and colleagues for their recent publication “U-rich elements drive pervasive cryptic splicing in 3’ UTR massively parallel reporter assays” in Nature Communications!
upcoming events
Our next THINC Seminar Series will be January 14th. The new seminar time will be 3:30pm at Helix Park-Dynamic One. Hope to see you there!
Our next RNA Group will be January 12th, at 10am in M112. Hope to see you there!